Annette Amon-hassenzahl PhD

Annette Amon-Hassenzahl is part of the Clinical Trial biosample management group at Merck KGaA and has responsibilities over early and late phase trials. Annette is involved in strategic alliance partnership management of biosample related vendors and is also the representative for risk base monitoring. Previously, Annette has worked for a clinical research organization as Global Clinical Trial Manager.